Income statement
USD
Annual
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -40K | -35K | -49K | -832K | -832K |
| EBITDA | 0 | 0 | 2M | -806K | -832K |
| Net Income | 7K | 525K | 2M | -1M | -1M |
| EPS (Diluted) | โ | โ | โ | โ | โ |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 8, 2026
Coverage: 242 bars ยท Jun 23, 2025 โ Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sector 10, Inc. (SECI) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 8, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -98.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -98.7%, free cash flow -99.8% with operating margin 0.0% and ROIC 0.4%. Valuation is more restrained than many high-expectation growth names at P/E 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SECI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SECI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SECI Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for SECI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$1.3M
+3.9% YoY
Free Cash Flow
$1.3K
-3.9% YoY
Revenue Growth
+0.0%
EPS Growth
-98.7%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -40K | -35K | -49K | -832K | -832K |
| EBITDA | 0 | 0 | 2M | -806K | -832K |
| Net Income | 7K | 525K | 2M | -1M | -1M |
| EPS (Diluted) | โ | โ | โ | โ | โ |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1K | 0 | 0 | 0 | 0 |
| Total Assets | 1K | 0 | 0 | 22K | 22K |
| Total Liabilities | 10M | 10M | 10M | 12M | 11M |
| Shareholder Equity | -10M | -10M | -10M | -12M | -11M |
| Total Debt | 164K | 164K | 321K | 804K | 804K |
| Net Debt | 163K | 164K | 321K | 804K | 804K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1K
-3.9% YoY
Capital Expenditures
0
Free Cash Flow
1K
-3.9% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-0.1%
Debt / Equity
-0.02x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.